Product Information

TOPIRAMATE ER 25 MG SPRINKL CAP is a generic product labeled by NorthStar Rx LLC, priced at $2.2700 per EA under NDC 72603012001. Its NADAC has been published 186 times since May 3, 2023.

FDA first approved this application on Feb 1, 2021. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TOPIRAMATE ER 25 MG SPRINKL CAP

topiramate
$2.2700per EA

Strength

25 mg/1

Manufacturer

NorthStar Rx LLC

NDC

72603012001

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

TOPIRAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA210278

FDA Approved

2/1/2021

TE Code

AB2

On Market Since

1/1/2023

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for TOPIRAMATE ER 25 MG SPRINKL CAP has been published 186 times since May 3, 2023, and over the history we have for it it has declined 47.1%. The table below summarizes its recorded NADAC range and movement.

Current price$2.2700 per EA
All-time high$5.1912 (Apr 10, 2024)
All-time low$2.2299 (Oct 21, 2026)
52-week high$3.7016
52-week low$2.2299
Median price$3.7915
Average price$3.8405
Largest weekly change+19.9% (Jul 19, 2023)
Weeks tracked186
Tracking sinceMay 3, 2023

Price History

1W

+1.8%

1M

+0.7%

3M

-2.8%

6M

-19.6%

1Y

-38.7%

3Y

-51.6%

5Y

N/A

All

-47.1%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TOPIRAMATE ER 25 MG SPRINKL CAP?

The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE ER 25 MG SPRINKL CAP, manufactured by NorthStar Rx LLC, is $2.2700 per EA (NDC 72603012001), effective Nov 18, 2026.

How has the price of TOPIRAMATE ER 25 MG SPRINKL CAP changed over time?

Over the history we have for it, the NADAC for TOPIRAMATE ER 25 MG SPRINKL CAP has declined 47.1%. It has been tracked across 186 weekly CMS publications since May 3, 2023.

What are the highest and lowest recorded NADAC prices for TOPIRAMATE ER 25 MG SPRINKL CAP?

Since May 3, 2023, the NADAC for TOPIRAMATE ER 25 MG SPRINKL CAP has ranged from a low of $2.2299 (Oct 21, 2026) to a high of $5.1912 (Apr 10, 2024), with a median of $3.7915 per EA.

Are there cheaper alternatives to TOPIRAMATE ER 25 MG SPRINKL CAP?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TOPIRAMATE ER 25 MG SPRINKL CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures TOPIRAMATE ER 25 MG SPRINKL CAP?

TOPIRAMATE ER 25 MG SPRINKL CAP (NDC 72603012001) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.